Industry Reports

Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally

Tuesday, September 29, 2026 - 19:48
0 2
Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally
Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.

Read More
Previous Article

Top stocks to buy or sell in F&O segment: Alkem Lab, KFin Tech, Amber Ent...

Next Article

This single stock made Rekha Jhunjhunwala richer by over ₹1,000 crore in Q2F...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

Bank of India expects NIM to rise to 2.55% in H2 FY27 after RBI rate hike

Bank of India expects NIM to rise to 2.55% in H2 FY2...

Saturday, October 24, 2026
0
2
Dubai regulatory action, MSRDC fees and Jagdishan-Chakraborty differences: What HDFC Bank’s internal probe examines

Dubai regulatory action, MSRDC fees and Jagdishan-Ch...

Saturday, October 24, 2026
0
2
Sonu Sood’s Mumbai property portfolio: How ₹3.52 crore Bokka Coffee rent is structured, how much he earns from HDFC Bank

Sonu Sood’s Mumbai property portfolio: How ₹3.52 cr...

Saturday, October 24, 2026
0
1
Goa cuts ATF VAT to 7% from 15% effective October 24: Will flight fares drop? All you need to know

Goa cuts ATF VAT to 7% from 15% effective October 24...

Saturday, October 24, 2026
0
2
IT majors look beyond backend ops to AI strategy advice

IT majors look beyond backend ops to AI strategy advice

Saturday, October 24, 2026
0
2
Nearly 58% of engineers want FDE roles, but 90% lack a clear upskilling path, says report

Nearly 58% of engineers want FDE roles, but 90% lack...

Saturday, October 24, 2026
0
1

Comments (0)

User